Ayuda
Ir al contenido

Dialnet


Resumen de Retinal Abnormalities and Blue Skin from Antiseizure Drug

Diane S. Aschenbrenner

  • * The Food and Drug Administration has issued a warning that some patients taking ezogabine (Potiga) to control seizures have developed pigment changes in the retina or blueness in their skin.

    * These adverse effects are becoming evident after prolonged use of ezogabine.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus